ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For New CTEP, RRP Grants

February 24, 1989

Two cancer center directors named: Michael Kastan at St. Jude, James Willson at Harold Simmons.

December 10, 2004

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

December 5, 1975